Literature DB >> 1320166

Evaluation of a subcutaneously implanted chamber for antibody production in rabbits.

D J Clemons1, C Besch-Williford, E K Steffen, L K Riley, D H Moore.   

Abstract

Polyclonal antibody production in subcutaneous chambers was compared to traditional antibody production methods in rabbits. The chamber, a sterilized plastic wiffle golf ball that had been surgically implanted in the subcutis of the thoracic region, was immunized via a percutaneous injection of antigen into the core of the ball through one of the perforations in the chamber wall. Rabbits bearing chambers were immunized on the same schedule and with the same concentrations of antigens as were provided the adjuvant injected rabbits. Fluid volumes of 12 to 22 ml could be removed from each chamber at weekly intervals. Chamber antibody to specific microbial antigens was equal to or better than serum antibody produced to the same antigens with Freund's or acrylamide adjuvants. The comfort of the rabbit, the ease in chamber immunization, and the recovery of high titer antibody in large volumes make the subcutaneous chamber an attractive method for polyclonal antibody production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320166

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  12 in total

1.  Characterization of DRGs, developmentally regulated GTP-binding proteins, from pea and Arabidopsis.

Authors:  M L Devitt; K J Maas; J P Stafstrom
Journal:  Plant Mol Biol       Date:  1999-01       Impact factor: 4.076

2.  Cloning, expression and biological function of the bovine CD40 homologue: role in B-lymphocyte growth and differentiation in cattle.

Authors:  A Hirano; W C Brown; D M Estes
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

3.  In vivo tropisms and kinetics of rat theilovirus infection in immunocompetent and immunodeficient rats.

Authors:  Michael T Drake; Cindy Besch-Williford; Matthew H Myles; Justin W Davis; Robert S Livingston
Journal:  Virus Res       Date:  2011-07-26       Impact factor: 3.303

4.  Tiny T antigen: an autonomous polyomavirus T antigen amino-terminal domain.

Authors:  M I Riley; W Yoo; N Y Mda; W R Folk
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Expression of recombinant parvovirus NS1 protein by a baculovirus and application to serologic testing of rodents.

Authors:  L K Riley; R Knowles; G Purdy; N Salomé; D Pintel; R R Hook; C L Franklin; C L Besch-Williford
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

6.  Cationic Liposome-Oligonucleotide Complex as an Alternative Adjuvant for Polyclonal Antibody Production in New Zealand White Rabbits (Oryctolaguscuniculus).

Authors:  Erin S Lee; Clinton Sc Walker; Jacob E Moskowitz; Valerie A Johnson; Lon V Kendall
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

7.  Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys.

Authors:  Anne Schaap-Nutt; Margaret A Scull; Alexander C Schmidt; Brian R Murphy; Raymond J Pickles
Journal:  Vaccine       Date:  2010-02-20       Impact factor: 3.641

8.  Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epithelium.

Authors:  Emmalene J Bartlett; Margaret Hennessey; Mario H Skiadopoulos; Alexander C Schmidt; Peter L Collins; Brian R Murphy; Raymond J Pickles
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

9.  Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague.

Authors:  Nicholas A Eisele; Deborah M Anderson
Journal:  Clin Vaccine Immunol       Date:  2009-10-14

10.  Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.

Authors:  Bo Liang; Shirin Munir; Emerito Amaro-Carambot; Sonja Surman; Natalie Mackow; Lijuan Yang; Ursula J Buchholz; Peter L Collins; Anne Schaap-Nutt
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.